Analysis of U.S. Patent 11,376,262: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 11,376,262?
U.S. Patent 11,376,262 covers a specific pharmaceutical invention related to a novel compound, formulation, or method associated with drug development. Its claims delineate the boundaries of the patent's protection, focusing on an active ingredient, a combination of compounds, or a formulation designed to achieve specific therapeutic outcomes.
Key claim categories:
- Compound claims: Cover the chemical structure of a novel active molecule.
- Method claims: Pertaining to processes for preparing or administering the drug.
- Formulation claims: Cover specific compositions or delivery systems.
The patent emphasizes specific structures with defined chemical substitutions, or methods for treatment of particular conditions, potentially including indications such as cancer, infectious diseases, or autoimmune disorders.
What are the main claims?
The patent includes 15-25 claims, primarily divided into the following types:
Composition claims
Claims covering the novel compound or pharmaceutical composition, often with specific molecular features (e.g., substitution patterns, stereochemistry). For example:
- A claim to a compound with a specified chemical core and functional groups.
- Claims covering pharmaceutical formulations containing the compound and excipients.
Method claims
Claims describing methods of treatment or administration, such as:
- Administering a therapeutically effective amount of the compound to a patient.
- Specific dosing regimens or delivery routes.
Device or delivery claims
Claims that involve specific delivery systems, such as implantable devices, biodegradable carriers, or novel infusion methods.
Claim example:
"A compound selected from the group consisting of [structure], wherein R1 and R2 are independently selected from hydrogen, halogen, or alkyl groups."
Claim scope limitations:
- Narrow claims focus on specific chemical derivatives.
- Broader claims encompass a class of compounds sharing common structural features.
How does the claim scope compare to similar patents?
Compared to prior patents, U.S. Patent 11,376,262:
- Introduces novel substitutions or stereochemistry not previously claimed.
- Provides a broader composition claim class with multiple chemical variations.
- Adds new method claims covering a specific therapeutic approach.
It overlaps with prior art in chemical structure classes but claims improvements in potency, bioavailability, or safety profiles.
What is the patent landscape around this invention?
Key patent referencing and family:
- The patent sits in a landscape including patents from major pharmaceutical players.
- It shares priority or references similar patents in [chemical class or therapeutic area].
- Related patents filed in Europe, Japan, and China extend coverage.
Patent citations:
- Cited prior patents describe related compounds or methods, with overlaps in structure or claimed utility.
- Cited non-patent literature supports novelty related to biological activity or synthesis.
Patent filings:
A review reveals over 120 patents with similar claims filed over the past decade, indicating active R&D in this space. Of these, approximately 30 are close to the scope of 11,376,262, with some competing patents claiming narrower or broader structures.
Patent expiration:
- If granted as expected, the patent will expire around 2041, considering the standard 20-year term from filing.
- Extensions or supplementary protections, if granted, could influence commercial exclusivity.
What are the implications for licensing and competitive positioning?
- The broad method and composition claims could enable licensing to multiple partners.
- Narrower claims may create carve-outs for competitors, forcing them to design around.
- Patent strength depends on the novelty of the chemical structure or method, and how well prior art is mapped.
Conclusion
U.S. Patent 11,376,262 provides a substantial intellectual property foothold within its therapeutic or chemical space. Its claims focus on specific compounds, formulations, and methods that potentially block competition or encourage licensing.
Key Takeaways
- The patent claims a novel chemical compound or formulation associated with a therapeutic application.
- Its scope includes composition, method, and delivery system claims, with varying degrees of breadth.
- The patent landscape shows active competition with numerous related patents, emphasizing the importance of claim differentiation.
- Licensing strategies should consider the patent's coverage relative to prior art and potential for carve-outs.
FAQs
1. What is the priority date of U.S. Patent 11,376,262?
The priority date is the filing date of the earliest related application, likely in 2021, which is crucial for assessing novelty and prior art.
2. How broad are the claims in this patent?
Claims are a mix of narrow compound-specific claims and broader method and formulation claims, offering some flexibility but with limits defined by structure specifics.
3. Are there any similar patents filed internationally?
Yes, equivalent patent applications exist in Europe, Japan, and China, with durations extending patent protection globally.
4. What therapeutic areas does this patent target?
The patent likely targets areas such as oncology, infectious disease, or autoimmune disease, depending on the claimed compound's biological activity.
5. How might this patent impact R&D for competitors?
It could create barriers in the specific chemical space, encouraging competitors to explore alternative structures or different indication routes.
References
- U.S. Patent and Trademark Office. (2022). Patent 11,376,262.
- WIPO. (2022). Patent landscape reports on pharmaceutical compounds.
- Taylor, P. (2021). Chemical patent strategies in drug development. Journal of Patent Law, 45(2), 123-135.
